Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isolation Bio (formerly General Automation Lab Technologies) is a biotechnology company specializing in high-throughput microbial isolation and cultivation. The company's core technology, the Prospector Discovery Platform, utilizes nanoscale cultivation chambers to isolate and grow thousands of individual bacterial strains in parallel, overcoming the limitations of traditional Petri dish methods. This platform enables researchers in academia and industry to discover previously unculturable microbes and accelerate the development of novel products in human health, agriculture, and environmental science. By automating the labor-intensive process of microbial screening and picking, Isolation Bio provides a scalable solution for microbiome research and the commercialization of live biotherapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on General Automation Lab Technologies.